Cargando…

Candidate drugs against SARS-CoV-2 and COVID-19

Outbreak and pandemic of coronavirus SARS-CoV-2 in 2019/2020 will challenge global health for the future. Because a vaccine against the virus will not be available in the near future, we herein try to offer a pharmacological strategy to combat the virus. There exists a number of candidate drugs that...

Descripción completa

Detalles Bibliográficos
Autores principales:	McKee, Dwight L., Sternberg, Ariane, Stange, Ulrike, Laufer, Stefan, Naujokat, Cord
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189851/ https://www.ncbi.nlm.nih.gov/pubmed/32360480 http://dx.doi.org/10.1016/j.phrs.2020.104859

Ejemplares similares

Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination
por: Sternberg, Ariane, et al.
Publicado: (2020)

Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?
por: Santos, Igor de Andrade, et al.
Publicado: (2020)

Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs
por: Jeon, Sangeun, et al.
Publicado: (2020)

Computational screening for potential drug candidates against the SARS-CoV-2 main protease
por: Silva Andrade, Bruno, et al.
Publicado: (2020)

Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
por: Aherfi, Sarah, et al.
Publicado: (2021)

Identification of synthetic vaccine candidates against SARS CoV infection
por: Lien, Shu-Pei, et al.
Publicado: (2007)

Development of DNA Vaccine Candidate against SARS-CoV-2
por: Wang, Xingyun, et al.
Publicado: (2022)

Salinomycin as a Drug for Targeting Human Cancer Stem Cells
por: Naujokat, Cord, et al.
Publicado: (2012)

Letter to the Editor in response to the article ‘Candidate drugs against SARS-CoV-2 and COVID-19’
por: Campesi, Ilaria, et al.
Publicado: (2021)

Naturally Available Flavonoid Aglycones as Potential Antiviral Drug Candidates against SARS-CoV-2
por: Al-Karmalawy, Ahmed A., et al.
Publicado: (2021)

COVID-19 therapeutics: Small-molecule drug development targeting SARS-CoV-2 main protease
por: Kronenberger, Thales, et al.
Publicado: (2023)

A candidate multi-epitope vaccine against SARS-CoV-2
por: Kar, Tamalika, et al.
Publicado: (2020)

Ebselen, a new candidate therapeutic against SARS-CoV-2
por: Haritha, C.V., et al.
Publicado: (2020)

Antiviral drugs against SARS-CoV-2
por: Aiello, Tommaso Francesco, et al.
Publicado: (2022)

Indole-Based Compounds as Potential Drug Candidates for SARS-CoV-2
por: Girgis, Adel S., et al.
Publicado: (2023)

A Scalable Topical Vectored Vaccine Candidate against SARS-CoV-2
por: Rohaim, Mohammed A., et al.
Publicado: (2020)

Identification of Potent and Safe Antiviral Therapeutic Candidates Against SARS-CoV-2
por: Xiao, Xia, et al.
Publicado: (2020)

Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs against COVID-19
por: Barh, Debmalya, et al.
Publicado: (2020)

Naringerin as candidate drug against SARS-CoV-2: The role for TPC2 genomic variants in COVID-19
por: Di Maria, Emilio, et al.
Publicado: (2021)

Predicting Epitope Candidates for SARS-CoV-2
por: Agarwal, Akshay, et al.
Publicado: (2022)

Network Controllability-Based Prioritization of Candidates for SARS-CoV-2 Drug Repositioning
por: Ackerman, Emily E., et al.
Publicado: (2020)

The development of Nanosota-1 as anti-SARS-CoV-2 nanobody drug candidates
por: Ye, Gang, et al.
Publicado: (2021)

Intranasal administration of cold-adapted live-attenuated SARS-CoV-2 candidate vaccine confers protection against SARS-CoV-2
por: Abdoli, Mohsen, et al.
Publicado: (2022)

Drug Weaponry to Fight Against SARS-CoV-2
por: Cabezón, Elena, et al.
Publicado: (2020)

Phytochemicals against SARS-CoV as potential drug leads
por: Swain, Shasank Sekhar, et al.
Publicado: (2021)

Recombinant Mycobacterium paragordonae Expressing SARS-CoV-2 Receptor-Binding Domain as a Vaccine Candidate Against SARS-CoV-2 Infections
por: Kim, Byoung-Jun, et al.
Publicado: (2021)

Quercetin: A promising drug candidate against the potential SARS-CoV-2-Spike mutants with high viral infectivity
por: Pan, Boyu, et al.
Publicado: (2023)

Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19
por: Sharun, Khan, et al.
Publicado: (2020)

Phytochemicals as potential drug candidates for targeting SARS CoV 2 proteins, an in silico study
por: Nag, Anish, et al.
Publicado: (2021)

Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections
por: Reinke, Patrick Y. A., et al.
Publicado: (2023)

Development of an inactivated vaccine candidate for SARS-CoV-2
por: Gao, Qiang, et al.
Publicado: (2020)

Candidate genes of SARS-CoV-2 gender susceptibility
por: Russo, Cristina, et al.
Publicado: (2021)

MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters
por: Boudewijns, Robbert, et al.
Publicado: (2022)

Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
por: Wang, Hui, et al.
Publicado: (2020)

Anti-HIV drug repurposing against SARS-CoV-2
por: Sang, Peng, et al.
Publicado: (2020)

Synergistic and Antagonistic Drug Combinations against SARS-CoV-2
por: Bobrowski, Tesia, et al.
Publicado: (2021)

Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2 In Vitro and SARS-CoV In Vivo
por: Weston, Stuart, et al.
Publicado: (2020)

DockCoV2: a drug database against SARS-CoV-2
por: Chen, Ting-Fu, et al.
Publicado: (2020)

In silico drug repurposing against SARS-CoV-2 using an integrative transcriptomic profiling approach: Hydrocortisone and Benzhydrocodone as potential drug candidates against COVID-19
por: Mirmohammadi, SeyedehMozhdeh, et al.
Publicado: (2022)

Immunogenic potential of DNA vaccine candidate, ZyCoV-D against SARS-CoV-2 in animal models
por: Dey, Ayan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r1f8cc4htt38e5et1epes71se8